000 | 01114 a2200289 4500 | ||
---|---|---|---|
005 | 20250516120130.0 | ||
264 | 0 | _c20121220 | |
008 | 201212s 0 0 eng d | ||
022 | _a1128-3602 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAli, N O M | |
245 | 0 | 0 |
_aLeishmania mexicana: expression; characterization and activity assessment of E. coli-expressed recombinant CRK3. _h[electronic resource] |
260 |
_bEuropean review for medical and pharmacological sciences _cOct 2012 |
||
300 |
_a1338-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aEscherichia coli _xgenetics |
650 | 0 | 4 | _aImmunoblotting |
650 | 0 | 4 |
_aLeishmania mexicana _xenzymology |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-crk _xantagonists & inhibitors |
650 | 0 | 4 |
_aRecombinant Proteins _xbiosynthesis |
700 | 1 | _aIbrahim, M E | |
700 | 1 | _aGrant, K M | |
700 | 1 | _aMottram, J C | |
773 | 0 |
_tEuropean review for medical and pharmacological sciences _gvol. 16 _gno. 10 _gp. 1338-45 |
|
999 |
_c22218786 _d22218786 |